Ken'ichi Nakamura

Latest

• Real-world Evidence of Skin Disorder-related Events Management in Patients with Lung Cancer Prescribed the RELAY Regimen (Erlotinib Plus Ramucirumab) - A Retrospective Observational Study Using A Health Insurance Claims Database in Japan [Article in Japanese] 肺癌患者におけるRELAYレジメン(エルロチニブ+ラムシルマブ)処方時の皮膚障害関連事象マネジメントの実態-日本のレセプトデータベースを用いた後ろ向き観察研究-